Ciprova Injection 100 ml

Ciprova Injection 100 ml is used to treat a wide range of bacterial infections. The detailed uses of Ciprova Injection 100 ml are as follows:

• Respiratory tract infections: Ciprova Injection 100 ml is used to treat lung and airway infections, such as pneumonia and bronchitis, caused by susceptible bacteria.
• Ear and sinus infections: Ciprova Injection 100 ml is effective against otitis media and acute bacterial sinusitis.
• Urinary tract infections (UTIs): Ciprova Injection 100 ml is used to treat both uncomplicated and complicated UTIs, including pyelonephritis (kidney infection).
• Genital tract infections: Ciprova Injection 100 ml is used to treat prostatitis, urethritis, and pelvic inflammatory disease caused by susceptible bacteria.
• Gastrointestinal infections: Ciprova Injection 100 ml is commonly prescribed for infectious diarrhoea and typhoid fever caused by susceptible bacteria.
• Intra-abdominal infections: Ciprova Injection 100 ml is used in combination with other antimicrobial agents to treat complicated abdominal infections, such as peritonitis.
• Skin and soft tissue infections: Ciprova Injection 100 ml is used to kill bacteria causing cellulitis, wound infections, and abscesses.
• Bone and joint infections: Ciprova Injection 100 ml is effective for the treatment of osteomyelitis and septic arthritis.
• Other infections: Ciprova Injection 100 ml is also used to prevent or treat anthrax after suspected exposure and as empirical therapy for patients with febrile neutropenia.

Ciprova Injection 100 ml offers the following medicinal benefits:

• Treats a wide range of bacterial infections affecting different parts of the body.
• Inhibits bacterial cell division and interferes with their ability to repair themselves, thereby killing the bacteria and clearing the infection.
• Effective in treating infections of the lungs and airways, bones, joints, urinary tract, kidneys, and reproductive system.
• Helps manage conditions such as infectious diarrhoea, typhoid fever, and intra-abdominal bacterial infections.
• Helps treat and prevent bacterial skin and soft-tissue infections, including infected wounds, cellulitis, and abscesses.
• Helps prevent or treat anthrax following suspected or confirmed exposure.
• Used as first-line therapy for patients with febrile neutropenia (a fever caused by a low white blood cell count).

• Follow your doctor's instructions on the dosage and timing of Ciprova Injection 100 ml to ensure its safe and effective use.
• Ciprova Injection 100 ml will be administered by your doctor or a healthcare professional.
• Do not self-administer it.

Gut health:

• Take probiotic foods after completing the antibiotic course to restore healthy gut bacteria.
• Consume fermented foods like yoghurt, cheese, sauerkraut, kombucha, and kimchi.
• Probiotics can help reduce the risk of diarrhoea after antibiotic use.

Dietary choices:

• Eat fibre-rich foods to support digestion and gut balance.
• Include whole grains, fruit, legumes, nuts, seeds, and vegetables in your diet to support gut health and immunity.

Hydration:

• Drink plenty of water or other fluids daily to flush out toxins and support recovery.

Lifestyle measures:

• Do not consume alcohol, as it can dehydrate the body, disturb sleep, and weaken immunity.
• Ensure adequate sleep to strengthen the immune system.
• Avoid overexertion and stress to allow the body to focus on fighting infection.
• Wash hands frequently and keep wounds clean and covered to prevent the spread of infection.

• Do not use Ciprova Injection 100 ml if you are allergic to any of its ingredients or to other quinolone or fluoroquinolone antibiotics.
• Before receiving Ciprova Injection 100 ml, inform your doctor if you have heart disease, peripheral neuropathy (nerve damage), electrolyte imbalances, muscle weakness, seizures, low blood sugar, low blood potassium levels, joint problems, or central nervous system disorders.
• Consult your doctor before receiving Ciprova Injection 100 ml if you are pregnant, planning to get pregnant, or breastfeeding.
• Children under 18 years of age are at a higher risk of developing bone, tendon, or joint problems while taking Ciprova Injection 100 ml; therefore, it should not be used as a first-line treatment in children.